US Patent Issued to The Trustees of the University of Pennsylvania, DANA-FARBER CANCER INSTITUTE on Sept. 8 for "Compounds for the treatment of human immunodeficiency virus" (Pennsylvania, Virginia, Massachusetts Inventors)

ALEXANDRIA, Va., Sept. 8 -- United States Patent no. 12,729,194, issued on Sept. 8, was assigned to The Trustees of the University of Pennsylvania (Philadelphia) and DANA-FARBER CANCER INSTITUTE (Boston).

"Compounds for the treatment of human immunodeficiency virus" was invented by Amos B. Smith III (Merion, Pa.), Althea Erica Gaffney (Alexandria, Va.) and Joseph G. Sodroski (Medford, Mass.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure provides compounds of Formula (I) or pharmaceutically acceptable salts thereof: (I) wherein, R1 to R6 and X are defined herein. Also provided are pharmaceutical compositions comprising these compounds, methods for treating Human Immunodeficiency Virus (...